In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.
This report contains market size and forecasts of IVD Antibodies in Global, including the following market information:
Global IVD Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global IVD Antibodies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cardiac Markers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of IVD Antibodies include Abcam, Thermo Fisher Scientific, Rockland Immunochemicals, GenScript, Bio-Rad Laboratories, SDIX, MEDICAL & BIOLOGICAL LABORATORIES, HyTest and Abbott. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IVD Antibodies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IVD Antibodies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global IVD Antibodies Market Segment Percentages, by Type, 2021 (%)
Cardiac Markers
Tumor Markers
Kidney Injury Markers
Global IVD Antibodies Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global IVD Antibodies Market Segment Percentages, by Application, 2021 (%)
Hospital
Specialty Clinic
Diagnostic Center
Others
Global IVD Antibodies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global IVD Antibodies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IVD Antibodies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies IVD Antibodies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abcam
Thermo Fisher Scientific
Rockland Immunochemicals
GenScript
Bio-Rad Laboratories
SDIX
MEDICAL & BIOLOGICAL LABORATORIES
HyTest
Abbott